查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009257

视网膜手术设备市场规模、份额、趋势和预测：按设备类型、应用、最终用途和地区划分，2026-2034 年

Retinal Surgery Devices Market Size, Share, Trends and Forecast by Equipment Type, Application, End-Use, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2025年全球视网膜手术设备市场规模为23亿美元。展望未来，IMARC集团预测，该市场将在2026年至2034年间以6.14%的复合年增长率成长，到2034年达到41亿美元。目前，北美市场主导地位，预计2025年将占据约35%的市场。推动该市场成长的主要因素是人口老化和糖尿病盛行率上升导致糖尿病视网膜病变和老龄化黄斑部病变（AMD）等视网膜疾病的日益普遍。微创手术（例如玻璃体切除手术）的技术进步正在改善治疗效果。医疗保健支出的成长、新兴市场眼科医疗服务可近性的提高以及政府促进早期诊断的措施进一步推动了市场需求。此外，研发投入的增加和创新设备的推出也进一步扩大了视网膜手术设备的市场份额。

视网膜疾病（例如老龄化黄斑部病变(AMD)、糖尿病视网膜病变和视网膜剥离）的日益普遍是推动该市场成长的主要因素。微创手术技术的进步，例如玻璃体切除手术(MIVS)，正在提高治疗效果和患者预后。此外，易患视网膜疾病的老年人口不断增加，也进一步刺激了市场需求。预计到 2080 年，全球人口将达到 103 亿的峰值，届时 65 岁及以上人口预计将达到 22 亿，超过 18 岁以下儿童人口。预期寿命也不断延长，预计将从 2024 年的 73.3 岁增长到 2054 年的 77.4 岁，这将导致老年人对眼科医疗服务的需求增加。与老化相关的人口结构变化凸显了投资尖端视网膜手术技术以改善全球快速增长的老年族群视觉健康的迫切需求。新兴经济体医疗保健支出不断增长以及获得先进眼科医疗服务的机会增加，也推动了视网膜手术设备市场的成长。政府的支持措施以及人们对早期诊断和治疗重要性的认识不断提高，也对市场扩张起到了重要作用。

美国作为重要的区域市场脱颖而出，这主要是由于慢性眼科疾病（尤其是老年族群）的盛行率不断上升。超过1200万40岁以上的美国成年人患有视力障碍，其中100万人完全失明。预计到2050年，这一数字将翻倍以上，主要原因是人口老化和糖尿病等慢性疾病。视力障碍位列美国成年人十大健康问题之列，其中90%的可预防性失明是由糖尿病视网膜病变引起的。预计到2050年，视力障碍造成的经济损失将达到3,730亿美元，因此对用于治疗这些不可避免的疾病的创新视网膜手术设备的需求庞大。糖尿病患者人数的增加加剧了对糖尿病视网膜病变治疗的需求，而玻璃体切除系统和手术雷射技术的进步正在改善治疗效果。完善的医疗保健基础设施和主要行业参与者的存在正在推动先进技术的快速应用。此外，患者意识的提高和积极主动的筛检计画有助于疾病的早期发现，并提高手术治疗品质。新医疗设备的监管核准和製造商之间的策略合作进一步刺激了市场扩张，并确保了尖端视网膜手术解决方案的稳定供应。

视网膜手术设备市场趋势：

眼科疾病发生率上升

在全球范围内，视力相关疾病的盛行率不断上升，是推动市场成长的主要因素。黄斑部病变、视网膜色素变性和糖尿病视网膜病变等疾病的发生率日益增高，尤其是在全球糖尿病患者和老年族群。此外，光是糖尿病视网膜病变就影响了全球25.2%的糖尿病患者，其中第1型糖尿病患者的发生率（约75%）显着高于第2型糖尿病患者（50%）。根据视网膜手术设备市场的预测，这些令人担忧的统计数据正在推动对高效手术解决方案的需求。需要精准治疗的病例数量不断增加，推动了视网膜手术设备的应用。这些设备被认为具有成本效益高、节省时间、手术效率高等优点。随着全球糖尿病患者数量的成长，这一趋势预计将持续下去，从而促进市场扩张。为此，医疗专业人员正优先考虑早期诊断和先进的手术干预，以有效控制进行性眼科疾病。

人口老化和与老龄化相关的视力丧失

全球人口老化是推动视网膜手术器械市场需求的另一个重要因素。老年人更容易患上与老龄化相关的眼科疾病，例如白内障、青光眼和老花眼。白内障的高发生率就是一个明显的例子。 45-54岁族群中，女性盛行率为4%，男性为2.4%；而75岁以上族群中，女性盛行率高达30.49%，男性为27.97%。随着全球人口老化，医疗领域对针对老年患者特定需求的先进手术介入措施的需求也相应增加。视网膜手术器械具有显着优势，例如减轻疼痛、减少疤痕和缩短恢復时间，这些优势对老年患者尤其具有吸引力。老年族群罹患慢性视力障碍的风险日益增加，促使医疗系统和医疗设备製造商投资于能够改善治疗效果并同时确保老年人舒适和安全的技术。因此，这进一步提升了视网膜手术器械的市场前景。

技术进步和糖尿病发生率上升

微创手术器械和设备的科技进步正在显着影响视网膜手术器械市场的未来。同时，全球糖尿病患者人数的快速成长也进一步刺激了对专业眼科医疗解决方案的需求。根据国际糖尿病联盟（IDF）统计，目前约有5.89亿成年人患有糖尿病，预计到2050年这数字将达到8.53亿。这种慢性疾病每年导致超过340万人死亡，也是糖尿病视网膜病变及相关视力障碍病例不断增加的主要原因。微创手术的兴起与更广泛的医疗需求趋势相吻合，即提高患者疗效、加快康復速度并提升安全性。视网膜手术器械的创新不仅能够带来这些好处，还能满足日益增长的糖尿病患者群体的独特医疗需求。技术创新与人口健康水准的提高，以及全球对治疗方法方案认知的不断增强，共同推动了市场成长。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球视网膜手术设备市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依设备类型划分

  • 玻璃体切除装置
  • 视网膜雷射设备
  • 手术器械
    • 主要类型
      • 套管
      • 钳子
      • 刀具
      • 低温探针
      • 其他的

第七章 市场区隔：依应用领域划分

  • 糖尿病视网膜病变
  • 视网膜剥离
  • 其他的

第八章 市场区隔：依最终用途划分

  • 医院
  • 眼科诊所
  • 其他的

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章 价格指标

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Alcon Management SA
    • Bausch & Lomb Incorporated
    • Carl Zeiss
    • Ellex Medical Lasers
    • Erbe Elektromedizin
    • Escalon Medicals
    • Iridex Corporation
    • Leica Microsystems GmbH
    • Lumenis
    • Nidek Co. Ltd.
    • Optos PLC
    • Second Sigh Medical Products
    • Synergetics USA Inc.
    • Topcon Corporation
Product Code: SR112026A2059

The global retinal surgery devices market size was valued at USD 2.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 4.1 Billion by 2034, exhibiting a CAGR of 6.14% during 2026-2034. North America currently dominates the market, holding a significant market share of around 35% in 2025. The market is driven by the rising prevalence of retinal disorders, including diabetic retinopathy and AMD, fueled by aging population and increasing diabetes cases. Technological advancements in minimally invasive surgeries, such as microincision vitrectomy, enhance treatment efficacy. Growing healthcare expenditure, improved access to eye care in emerging markets, and government initiatives promoting early diagnosis further propel demand. Additionally, increasing R&D investments and the introduction of innovative devices are further expanding the retinal surgery devices market share.

The market is driven by the rising prevalence of retinal disorders such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal detachment. Technological advancements in minimally invasive surgical techniques, such as microincision vitrectomy surgery (MIVS), enhance treatment efficacy and patient outcomes. Additionally, the growing geriatric population, which is more susceptible to retinal diseases, fuels market demand. By 2080, the global number of individuals aged 65 and above is expected to stand at 2.2 billion, outnumbering children under the age of 18, against a background of a peak global population of 10.3 billion in the 2080s. Life expectancy is also increasing, rising from 73.3 years in 2024 to 77.4 years in 2054, resulting in increased demand for eye care services among the elderly population. The changing demographics of the aging population indicate the urgent need for investment in cutting-edge retinal surgery technologies to improve vision health in the fast-growing geriatric markets around the world. Increased healthcare expenditure and improved access to advanced ophthalmic care in emerging economies further contribute to the retinal surgery devices market growth. Supportive government initiatives and increasing awareness about early diagnosis and treatment also play a significant role in expanding the market.

The United States stands out as a key regional market, primarily driven by the rising incidences of chronic eye conditions, particularly among the aging population. Over 12 million U.S. adults aged 40 and older have vision impairment, including 1 million who are blind. The number is estimated to more than double by the year 2050, mostly due to aging and chronic conditions such as diabetes. Vision disability ranks among the leading ten health problems in U.S. adults, with diabetic retinopathy causing 90% of cases of preventable blindness. Since the economic cost of vision impairment is likely to hit USD 373 Billion by 2050, demand for innovative retinal surgery equipment to treat such inescapable disorders is high. Increasing cases of diabetes contribute to higher demand for diabetic retinopathy treatments, while innovations in vitrectomy systems and surgical lasers improve procedural outcomes. Strong healthcare infrastructure and the presence of major industry players drive rapid adoption of advanced technologies. Additionally, heightened patient awareness and proactive screening programs facilitate early disease detection, improving surgical interventions. Regulatory approvals for novel devices and strategic collaborations among manufacturers further stimulate market expansion, ensuring a steady pipeline of cutting-edge retinal surgical solutions.

RETINAL SURGERY DEVICES MARKET TRENDS:

Rising Eye Disorder Prevalence

The increasing global prevalence of vision-related disorders among the masses is a major catalyst for growth in the market. Conditions such as macular degeneration, retinitis pigmentosa, and diabetic retinopathy are becoming more widespread, especially among diabetic and aging populations across the globe. Along with this, diabetic retinopathy alone affects 25.2% of individuals living with diabetes worldwide, with a significantly higher occurrence in type 1 diabetics (approximately 75%) compared to 50% in type 2 diabetics. According to the retinal surgery devices market forecast, these alarming statistics are pushing the demand for effective and efficient surgical solutions. The rise in cases requiring precise treatment is leading to increased adoption of retinal surgery devices, which are considered cost-effective, time-saving, and highly efficient during procedures. With a growing global diabetic population, this trend is expected to persist, supporting market expansion. In response, healthcare providers are prioritizing early diagnosis and advanced surgical interventions to manage progressive eye diseases effectively.

Geriatric Population and Age-Related Vision Loss

The aging demographic worldwide is another prominent factor enhancing the retinal surgery devices market demand. Elderly individuals are more susceptible to age-related ocular diseases such as cataracts, glaucoma, and presbyopia. Cataract prevalence provides a clear example: among individuals aged 45-54, the condition affects 4% of females and 2.4% of males, which dramatically increases to 30.49% in females and 27.97% in males aged 75 and above. As the global population continues to age, the healthcare sector is experiencing a corresponding rise in the need for advanced surgical interventions tailored to the unique requirements of older patients. Retinal surgery devices offer significant benefits, including less pain, minimal scarring, and quicker recovery times, which are particularly appealing for geriatric patients. This demography's growing vulnerability to chronic vision issues is encouraging healthcare systems and device manufacturers to invest in technologies that improve outcomes while ensuring comfort and safety for older individuals. Therefore, this is further creating a positive retinal surgery devices market outlook.

Technological Advancements and Rising Diabetes Incidence

Technological progress in minimally invasive surgical tools and equipment is significantly shaping the future of the retinal surgery devices market. Simultaneously, the steep rise in global diabetes cases is creating further demand for specialized eye care solutions. According to the International Diabetes Federation (IDF), nearly 589 million adults currently live with diabetes, a number projected to rise to 853 million by 2050. This chronic condition contributes to more than 3.4 million deaths each year and is a key driver behind the increasing cases of diabetic retinopathy and related vision issues. The shift towards minimally invasive surgeries aligns with the broader push for better patient outcomes, faster recovery, and enhanced safety. Innovations in retinal surgery devices are offering these benefits while catering to the growing diabetic population's unique medical needs. As awareness of treatment options spreads globally, this convergence of technological innovation and health demographics is propelling market growth.

RETINAL SURGERY DEVICES INDUSTRY SEGMENTATION:

Analysis by Equipment Type:

  • Vitrectomy Machines
  • Retinal Laser Equipment
  • Surgical Instruments
    • Cannulas
    • Forceps
    • Cutters
    • Cryoprobes
    • Others

Vitrectomy machines stand as the largest component in 2025, holding around 44.8% of the market, driven by their critical role in treating complex retinal conditions, such as diabetic retinopathy, retinal detachment, and macular holes. These advanced systems enable precise removal of vitreous gel and scar tissue while minimizing trauma to surrounding structures, improving surgical outcomes. According to the retinal surgery devices market research report, the shift toward minimally invasive vitrectomy surgery (MIVS) with smaller-gauge instruments has further increased adoption, reducing recovery times and complications. Technological advancements, including high-speed cutters, integrated fluidics, and enhanced visualization systems, enhance surgical efficiency and safety. Additionally, the rising prevalence of retinal diseases, an aging population, and increasing diabetic cases contribute to sustained demand. Leading manufacturers continue to innovate, introducing portable and user-friendly systems that expand accessibility in both hospitals and ambulatory surgical centers. With superior efficacy and expanding applications, vitrectomy machines remain indispensable in retinal surgery, securing their position as the leading equipment type in the market.

Analysis by Application:

  • Diabetic Retinopathy
  • Retinal Detachment

Diabetic retinopathy leads the market with around 40.6% of market share in 2025, primarily due to the escalating global prevalence of diabetes and its associated ocular complications. As a leading cause of vision loss among working-age adults, this progressive condition demands advanced surgical interventions such as vitrectomy and laser photocoagulation to manage vitreous hemorrhages, retinal detachment, and macular edema. The growing diabetic population, coupled with poor glycemic control in many patients, fuels the need for early and aggressive treatment, driving demand for specialized retinal surgery devices. Additionally, increasing awareness about diabetes-related eye complications and improved screening programs have led to earlier diagnosis, expanding the patient pool requiring surgical care. Technological advancements in imaging and microsurgical tools further enhance treatment precision, supporting segment growth. With diabetes rates continuing to rise worldwide, particularly in aging populations, diabetic retinopathy is expected to maintain its dominance as the key application driving the retinal surgery devices market.

Analysis by End-Use :

  • Hospitals
  • Ophthalmology Clinics

Hospitals lead the market with around 60.1% of market share in 2025, due to their advanced infrastructure, availability of skilled ophthalmologists, and ability to handle complex retinal procedures. Equipped with state-of-the-art operating rooms and diagnostic tools, hospitals are the primary settings for vitrectomies, retinal detachment repairs, and other intricate eye surgeries. The increasing prevalence of retinal disorders, coupled with rising hospital admissions for vision-related conditions, further drives demand in this segment. Additionally, hospitals often serve as referral centers for specialized ophthalmic care, attracting patients requiring advanced surgical interventions. The growing adoption of minimally invasive retinal surgeries in hospital settings, supported by favorable reimbursement policies, also contributes to segment dominance. With continuous investments in healthcare infrastructure and the integration of cutting-edge surgical technologies, hospitals remain the preferred choice for retinal treatments, reinforcing their position as the leading end-use segment in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 35%, driven by advanced healthcare infrastructure, high adoption of innovative surgical technologies, and a significant patient pool suffering from retinal disorders. The region's leadership is reinforced by the rising prevalence of diabetes and age-related macular degeneration (AMD), increasing demand for vitrectomy and other retinal procedures. Well-established reimbursement policies, particularly in the U.S., enhance patient access to advanced treatments, while strong R&D investments by key industry players accelerate product development. Additionally, the presence of leading ophthalmic centers and skilled surgeons supports the adoption of cutting-edge devices. High awareness about retinal health and proactive screening programs further contribute to early diagnosis and surgical intervention. With continuous technological advancements and favorable regulatory frameworks, North America remains the largest and most influential regional segment in the global retinal surgery devices market.

KEY REGIONAL TAKEAWAYS:

UNITED STATES RETINAL SURGERY DEVICES MARKET ANALYSIS

In 2025, the US accounted for around 85.80% of the total North America retinal surgery devices market. The United States market is primarily driven by the increasing prevalence of retinal disorders, including age-related macular degeneration (AMD) and diabetic retinopathy. According to the CDC, in 2021, approximately 9.6 million individuals in the United States were affected by diabetic retinopathy (DR). Among them, 1.84 million were experiencing vision-threatening forms of DR. In line with this, continual advancements in retinal imaging and diagnostic technologies, enabling earlier detection and more accurate treatment of retinal conditions, are propelling market growth. Furthermore, the rising aging population, which is more susceptible to retinal diseases, is contributing to market demand. Additionally, the growing adoption of minimally invasive procedures, with these techniques offering quicker recovery times and reduced risks, is driving the market expansion. The enhanced surgical outcomes facilitated by innovations in retinal surgery devices, such as improved lasers and surgical microscopes, are stimulating market appeal. Similarly, the increased awareness of retinal diseases and advancements in personalized medicine are expanding the market scope. Moreover, favorable reimbursement policies and government initiatives promoting eye health are creating lucrative opportunities in the market.

EUROPE RETINAL SURGERY DEVICES MARKET ANALYSIS

The market in Europe is experiencing growth due to increasing geriatric population leading to a higher prevalence of age-related macular degeneration and diabetic retinopathy. As per an industry report, in Europe, age-related macular degeneration (AMD) affects about 67 million individuals, projected to reach 77 million by 2050. Prevalence rises from 5% in ages 55-64 to 17.4% in those over 85, with 1.4 late-stage AMD cases per 1,000 individuals aged 60+, annually. Similarly, enhanced reimbursement policies in key European countries are making retinal procedures more accessible in the market. The growing adoption of minimally invasive vitreoretinal surgery techniques fueling the need for precision instruments, is fostering market expansion. Furthermore, continuous innovation by European manufacturers in micro-incision and illumination technologies is accelerating higher product uptake. The rising awareness campaigns and proactive screening initiatives improving early diagnosis rates are enhancing market appeal. Additionally, the expansion of ophthalmology training programs contributing to a skilled workforce, enabling the safe use of complex devices, is bolstering market development. Besides this, numerous cross-border healthcare collaborations and harmonized regulatory frameworks within the EU encouraging product approvals and regional distribution, are providing an impetus to the market.

ASIA PACIFIC RETINAL SURGERY DEVICES MARKET ANALYSIS

The Asia Pacific market is being propelled by the changing lifestyles, rising diabetes rates, and increasing diabetic retinopathy cases. According to NCBI, the number of individuals with diabetes in India rose sharply from 33 million in 2000 to 72 million in 2021 and is expected to reach 125 million by 2045. In accordance with this, rising investments in public and private healthcare infrastructure, improving access to advanced ophthalmic procedures, are supporting market expansion. The increasing presence of a large patient pool and rising disposable incomes is increasing the affordability and demand in the market. Furthermore, the expansion of medical tourism across Southeast Asia, heightening the requirement for cutting-edge retinal surgical technologies, is a significant market driver. Additionally, the growing presence of device makers in the region, augmenting access to innovative retinal surgery tools suited to local needs, is impelling the market. Moreover, favorable government-led health initiatives in countries including India and China, promoting eye health awareness and early detection, are impacting the market dynamics.

LATIN AMERICA RETINAL SURGERY DEVICES MARKET ANALYSIS

In Latin America, the market is advancing due to increasing rates of chronic eye conditions such as retinal detachment and macular holes, particularly in aging populations. Furthermore, various government-led efforts to expand universal healthcare coverage are enhancing access to ophthalmic surgeries in the market. As per NCBI, 14.14% of the population in Latin America suffers from moderate to severe vision impairment and blindness. Blindness is most prevalent in Tropical Latin America at 3.89%, and least in Southern Latin America at 0.96%. The rising awareness about preventable blindness fostering early diagnosis and timely interventions, is propelling the market growth. In addition to this, numerous regional partnerships with global manufacturers are driving advanced surgical tech and training adoption, augmenting outcomes in public and private care.

MIDDLE EAST AND AFRICA RETINAL SURGERY DEVICES MARKET ANALYSIS

The market in the Middle East and Africa is significantly progressing attributed to the growing burden of inherited retinal disorders. Similarly, increasing penetration of vision care services in underserved rural areas, expanding the treatment base, is impelling development in the market. Furthermore, the rising prevalence of hypertension and lifestyle-related conditions is leading to a rise in retinal vascular complications is driving the need for precision retinal surgery tools and advanced diagnostic equipment, thereby expanding market reach. According to NCBI, hypertension affects approximately 36% of the general population in the African region. Apart from this, strategic collaborations with international ophthalmic organizations, enhancing clinical training and knowledge transfer, are influencing the market dynamics.

COMPETITIVE LANDSCAPE:

The competitive landscape of the market is characterized by intense rivalry among key players striving to strengthen their market position. Companies are focusing on technological advancements, launching next-generation devices with enhanced precision, efficiency, and minimally invasive capabilities. Strategic collaborations, mergers, and acquisitions are common as firms aim to expand their product portfolios and geographic reach. Investments in research and development are prioritized to introduce innovative solutions for complex retinal conditions. Additionally, players are emphasizing regulatory approvals and clinical validations to ensure product efficacy and safety. Marketing strategies include educational initiatives to raise awareness among healthcare professionals, while competitive pricing and after-sales support further drive adoption. The market also sees a growing emphasis on portable and user-friendly systems to cater to diverse clinical settings, reinforcing competition.

The report provides a comprehensive analysis of the competitive landscape in the retinal surgery devices market with detailed profiles of all major companies, including:

  • Alcon Management S. A.
  • Bausch & Lomb Incorporated
  • Carl Zeiss
  • Ellex Medical Lasers
  • Erbe Elektromedizin
  • Escalon Medicals
  • Iridex Corporation
  • Leica Microsystems GmbH
  • Lumenis
  • Nidek Co. Ltd.
  • Optos PLC
  • Second Sigh Medical Products
  • Synergetics USA Inc.
  • Topcon Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the retinal surgery devices market?

2. What is the future outlook of the retinal surgery devices market?

3. What are the key factors driving the retinal surgery devices market?

4. Which region accounts for the largest retinal surgery devices market share?

5. Which are the leading companies in the global retinal surgery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Retinal Surgery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Equipment Type

  • 6.1 Vitrectomy Machines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Retinal Laser Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Surgical Instruments
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Cannulas
      • 6.3.2.2 Forceps
      • 6.3.2.3 Cutters
      • 6.3.2.4 Cryoprobes
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Diabetic Retinopathy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retinal Detachment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ophthalmology Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Alcon Management S. A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bausch & Lomb Incorporated
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Carl Zeiss
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Ellex Medical Lasers
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Erbe Elektromedizin
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Escalon Medicals
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Iridex Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Leica Microsystems GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Lumenis
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Nidek Co. Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Optos PLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Second Sigh Medical Products
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Synergetics USA Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
    • 14.3.14 Topcon Corporation
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials

List of Figures

  • Figure 1: Global: Retinal Surgery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Retinal Surgery Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Retinal Surgery Devices Market: Breakup by Equipment Type (in %), 2025
  • Figure 4: Global: Retinal Surgery Devices Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Retinal Surgery Devices Market: Breakup by End-Use (in %), 2025
  • Figure 6: Global: Retinal Surgery Devices Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Retinal Surgery Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 8: Global: Retinal Surgery Devices (Vitrectomy Machines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Retinal Surgery Devices (Vitrectomy Machines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Retinal Surgery Devices (Surgical Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Retinal Surgery Devices (Surgical Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Retinal Surgery Devices (Retinal Detachment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Retinal Surgery Devices (Retinal Detachment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Retinal Surgery Devices (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Retinal Surgery Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Retinal Surgery Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Retinal Surgery Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Retinal Surgery Devices (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Retinal Surgery Devices (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: North America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: North America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: United States: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: United States: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Canada: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Canada: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Asia Pacific: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Asia Pacific: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: China: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: China: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Japan: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Japan: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: India: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: India: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: South Korea: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: South Korea: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Australia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Australia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Indonesia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Indonesia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Latin America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Latin America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Brazil: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Brazil: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Mexico: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Mexico: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Middle East and Africa: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Middle East and Africa: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Global: Retinal Surgery Devices Industry: SWOT Analysis
  • Figure 75: Global: Retinal Surgery Devices Industry: Value Chain Analysis
  • Figure 76: Global: Retinal Surgery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Retinal Surgery Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Retinal Surgery Devices Market Forecast: Breakup by Equipment Type (in Million USD), 2026-2034
  • Table 3: Global: Retinal Surgery Devices Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Retinal Surgery Devices Market Forecast: Breakup by End-Use (in Million USD), 2026-2034
  • Table 5: Global: Retinal Surgery Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Retinal Surgery Devices Market: Competitive Structure
  • Table 7: Global: Retinal Surgery Devices Market: Key Players